Acumen Pharmaceuticals, Inc.
ABOSNASDAQHealthcare● Active
$2.27
+$0.10(+4.52%)
Market Cap$137386529
P/E Ratio—
52W High$3.6
52W Low$1.05
Acumen Pharmaceuticals, Inc.（ABOS）· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ABOS · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.12B | $0.17B | $0.24B | $0.18B | $0.19B |
| Net Receivables | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Inventory | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Current Assets | $0.12B | $0.18B | $0.25B | $0.18B | $0.20B |
| PP&E Net | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Assets | $0.12B | $0.24B | $0.31B | $0.20B | $0.23B |
| Liabilities | |||||
| Short-Term Debt | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| Accounts Payable | $0.00B | $0.01B | $0.00B | $0.00B | $0.00B |
| Total Current Liabilities | $0.03B | $0.03B | $0.01B | $0.01B | $0.01B |
| Long-Term Debt | $0.02B | $0.03B | $0.03B | $0.00B | $0.00B |
| Total Liabilities | $0.05B | $0.06B | $0.04B | $0.01B | $0.01B |
| Stockholders Equity | |||||
| Retained Earnings | ($0.45B) | ($0.33B) | ($0.22B) | ($0.17B) | ($0.13B) |
| Total Stockholders Equity | $0.07B | $0.18B | $0.27B | $0.19B | $0.23B |
| Total Liab & Equity(computed) | $0.12B | $0.24B | $0.31B | $0.20B | $0.23B |
| Debt Summary | |||||
| Total Debt | $0.03B | $0.03B | $0.03B | $0.00B | $0.00B |
| Net Debt | ($0.02B) | ($0.01B) | ($0.04B) | ($0.13B) | ($0.12B) |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Acumen Pharmaceuticals, Inc.
关于Acumen Pharmaceuticals, Inc.（ABOS）资产负债表
Acumen Pharmaceuticals, Inc.总资产$0.12B，现金及短期投资$0.12B，总负债$0.05B，总债务$0.03B，股东权益$0.07B。
常见问题
ABOS · 4 问Acumen Pharmaceuticals, Inc.总债务$0.03B，净债务($0.02B)。
ABOS total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10